Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals
Indiana HIV epidemic among people who inject drugs is controlled, but ongoing vigilance is needed
Ravidasvir plus sofosbuvir demonstrates high cure rate for people with hepatitis C genotype 4
Life expectancy in HIV-positive people in the US still lags 13 years behind HIV-negative people
Sofosbuvir/ledipasvir for 6 weeks cures HCV in HIV-positive people with acute HCV if viral load is low
